Friday, March 26, 2021

Second Sight Medical Raises $27.9M In Private Placement

Los Angeles-based Second Sight Medical Products, a developer of implantable visual prosthetics which it intends to use to provide artificial vision to blind individuals, says it has raised $27.9M in a private placement. The publicly traded company--which trades as EYES on the NASDAQ--said it sold 4,650,000 shares of common stock at a price of $6.00 p

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.